Aqueous Solubility in Drug Discovery Chemistry, DMPK, and Biological Assays

Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability

Volumn 40, Issue , 2009, Pages 7-31

  Colclough, Nicola ^a   Ruston, Linette ^a   Tam, Kin ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Aqueous solubility; Biological assays; Drug discovery; Drug metabolism; Powder X ray diffraction

Indexed keywords

SOLUBILITY;

AQUEOUS SOLUBILITY; BIOLOGICAL ASSAYS; DRUG DISCOVERY; DRUG METABOLISMS; POWDER X RAY DIFFRACTION;

DRUG DELIVERY;

EID: 85017622871     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527623860.ch2     Document Type: Chapter

References (46)

1. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3-26.
2. Kerns, E. (2001) High throughput physicochemical profiling for drug discovery. Journal of Pharmaceutical Sciences, 90 (11), 1838-1858.
3. Di, L. and Kerns, E.H. (2006) Biological assay challenges from compound solubility: strategies for bioassay optimisation. Drug Discovery Today, 11 (9-10), 446-451.
4. McGovern, S.L., Caselli, E., Grigorieff, N. and Shoichet, B.K. (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. Journal ofMedicinal Chemistry, 45, 1712-1722.
5. van de Waterbeemd, H., Smith, D.A., Beaumont, K. and Walker, D.K. (2001) Property-based design: optimization of drug absorption and pharmacokinetics. Journal ofMedicinal Chemistry, 44, 1-21.
6. Sunesen, V.H., Vedelsdal, R., Kristensen, H.G., Christrup, L. and Mullertz, A. (2005) Effect ofliquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. European Journal of Pharmaceutical Sciences, 24, 297-303.
7. Gu, C.H., Li, H., Levons, J., Lentz, K., Gandhi, R.B., Raghavan, K. and Smith, R.L. (2007) Predicting effect of food on extent of drug absorption based on physicochemical properties. Pharmaceutical Research, 24 (6), 1118-1130.
8. Mass, J., Kamm, W. and Hauck, G. (2007) An integrated early formulation strategy - from hit evaluation to preclinical candidate profiling. European Journal ofPharmaceutics and Biopharmaceutics, 66, 1-10.
9. Schmid, E.F. and Smith, D.A. (2007) Pharmaceutical R&D in the spotlight: why is there still unmet medical need? Drug Discovery Today, 12, 998-1006.
10. a, in Drug Bioavailability. Methods and Principles in Medicinal Chemistry, Vol. 8 (eds H. van de Waterbeemd, H. Lennernas and P. Artursson), Wiley-VCH Verlag GmbH, Weinheim, pp. 21-43.
11. Serajuddin, A.T.M. (2007) Salt formation to improve drug solubility. Advanced Drug Delivery Reviews, 59, 603-616.
12. Zhou, L., Yang, L., Tilton, S. and Wang, J. (2007) Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery. Journal ofPharmaceutical Sciences, 96 (11), 3052-3071.
13. Pan, L., Ho, Q., Tsutsui, K. and Takahashi, L. (2001) Comparison ofchromatographic and spectroscopic methods used to rank compounds for aqueous solubility. Journal ofPharmaceutical Sciences, 90 (4), 521-529.
14. Fligge, T.A. and Schuler, A. (2006) Integration ofa rapid automated solubility classification into early validation of hits obtained by high throughput screening. Journal ofPharmaceutical and Biomedical Analysis, 42, 449-454.
15. Popa-Burke, I.G., Issakova, O., Arroway, J. D., Bernasconi, P., Chen, M., Coudurier, L., Galasinski, S., Jadhav, A.P., Janzen, W.P., Lagasca, D., Liu, D., Lewis, R.S., Mohney, R.P., Sepetov, N., Sparkman, D.A. and Hodge, C.N. (2004) Streamlined systemfor purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation ofbiological assay results. Analytical Chemistry, 76, 7278-7287.
16. Sugano, K., Kato, T., Suzuki, K., Keiko, K., Sujaku, T. and Mano, T. (2006) High throughput solubility measurement with automated polarized light microscopy analysis. Journal ofPharmaceutical Sciences, 95 (10), 2115-2122.
17. Bevan, C. and Lloyd, R.S. (2000) A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in micro-titer plates. Analytical Chemistry, 72, 1781-1787.
18. Dehring, K.A., Workman, H.L., Miller, K. D., Mandagere, A. and Poole, S.K. (2004) Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility. Journal of Pharmaceutical and Biomedical Analysis, 36, 447-456.
19. Lilley, M., Shanter, M., Ardiff, M., Ciolkosz, T., Kashdan, M., Aubin, C. and Goodwin, J. A fully automated workstation for testing flow based kinetic solubility of compounds. Poster Presentation, BD Biosciences, Two Oak Park, Bedford, MA, USA.
20. Chen, T., Shen, H. and Zhu, C. (2002) Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. Combinatorial Chemistry & High Throughput Screening, 5, 575-581.
21. Avdeef, A. (2001) Pharmacokinetic optimization in drug research, in Biological, Physicochemical, and Computational Strategies (eds B. Testa, H. van de Waterbeemd, G. Folkers and R. Guy), Verlag Helvetica Chimica Acta, Zurich, pp. 305-326.
22. Alsenz, J. and Kansy, M. (2007) High throughput solubility measurement in drug discovery and development. Advanced Drug Delivery Reviews, 59, 546-567.
23. Colclough, N., Hunter, A., Kenny, P.W., Kittlety, R.S., Lobedan, L., Tam, K.Y. and Timms, M.A. (2008) High throughput solubility determination with application to selection of compounds for fragment screening. Bioorganic & Medicinal Chemistry, 16, 6611-6616.
24. Pudipeddi, M. and Serajuddin, A.T.M. (2005) Trends in solubility ofpolymorphs. Journal of Pharmaceutical Sciences, 94 (5), 929-939.
25. Yalkowsky, S.H. (1999) Solubility and Solubilisation in Aqueous Media, Oxford University Press, Cambridge, pp. 81-115, Table 4.8.
26. Hancock, B. and Parks, M. (2000) What is the true solubility advantage for amorphous pharmaceuticals. Pharmaceutical Research, 17 (4), 397-404.
27. Bhattachar, S.N., Welsey, J.A. and Seadeek, S. (2006) Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery. Journal of Pharmaceutical and Biomedical Analysis, 41, 152-157.
28. Hill, A. (2007) High-throughput solubility. PhysChem Forum 3, June 2007.
29. Reilly, J. (2007) CAD detector validation and potential for physicochemical measurements. PhysChem Forum 3, June 2007.
30. Glomme, A., Marz, J. and Dressman, J.B. (2005) Comparison ofa minaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. Journal of Pharmaceutical Sciences, 94 (1), 1-16.
31. Alelyunas, Y. (2006) Exploring the solubility limit of CNS discovery candidates. CHI's Molecular Medicine TriConference, February 21-25, San Francisco, CA.
32. Seadeek, C., Ando, H., Bhattachar, S.N., Heimbach, T., Sonnenberg, J.L. and Blackburn, A.C. (2007) Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. Journal of Pharmaceutical and Biomedical Analysis, 43, 1660-1666.
33. Wyttenbach, N., Alsenz, J. and Grassmann, O. (2007) Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development. Pharmaceutical Research, 24 (5), 888-898.
34. Alsenz, J., Meister, E. and Haenel, E. (2007) Development ofa partially automated solubility screening (PASS) assay for early drug development. Journal of Pharma-ceutical Sciences, 96 (7), 1748-1762.
35. Lipinski, C.A. (2004) Solubility in water and DMSO: issues and potential solutions. Pharmaceutical Profiling in Drug Discovery, 1, 93-125.
36. Buckton, G. (2002) Solid state properties, in Pharmaceutics: The Science ofDosage Form Design (ed. M.E. Aulton), Churchill Livingstone, Edinburgh, pp. 141-151.
37. Huang, L.F. and Tong, W.Q. (2004) Impact of solid state properties on developability assessment of drug candidates. Advanced Drug Delivery Reviews, 56, 321-334.
38. Avdeef, A. (2007) Solubility of sparingly-soluble ionizable drugs. Advanced Drug Delivery Reviews, 59, 568-590.
39. Avdeef, A., Berger, C.M. and Brownell, C. (2000) pH-metric solubility. 2. Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharmaceutical Research, 17 (1), 85-89.
40. Stuart, M. and Box, K. (2005) Chasing equilibrium: measuring the intrinsic solubilityofweakacids andbases. Analytical Chemistry, 77, 983-990.
41. Llinas, A., Burley, J.C., Box, K.J., Glen, R.C. and Goodman, J.M. (2007) Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms. Journal of Medicinal Chemistry, 50, 979-983.
42. Box, K.J., Volgyi, G., Baka, E., Stuart, M., Takacs-Novak, K. and Comer, J.E.A. (2006) Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution: a validation study. Journal of Pharmaceutical Sciences, 95 (6), 1298-1307.
43. Llinas, A., Box, K.J., Burley, J.C., Glen, R.C. and Goodman, J.M. (2007) A new method for the reproducible generation of polymorphs: two forms of sulindac with very different solubilities. Journal of Applied Crystallography, 40, 379-381.
44. Bruneau, P. (2001) Search for predictive generic model of aqueous solubility using Bayesian neural nets. Journal of Chemical Information and Computer Sciences, 41, 1605-1616.
45. Leach, A.G., Jones, H.D., Cosgrove, D.A., Kenny, P.W., Ruston, L., Macfaul, P., Wood, J.M., Colclough, N. and Law, B. (2006) Matched molecular pairs as a guide in the optimization of pharmaceutical properties: a study of aqueous solubility, plasma protein binding and oral exposure. Journal ofMedicinal Chemistry, 49 (23), 6672-6682.
46. Haubertin, D.Y. and Bruneau, P. (2007) A database of historically observed chemical replacements. Journal of Chemical Information and Modeling, 47, 1294-1302.